Press Releases
View News Archive >

Microsoft HealthVault Connectivity Added to OmniComm’s TrialMasterTM EDC Solution

Cutting-Edge Technology Used to Link Clinical Trial and Healthcare Data

FORT LAUDERDALE, FL--(Marketwire – 1/25/10) - OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the electronic data capture (EDC) marketplace, today announced that the company’s TrialMaster EDC product has connected to Microsoft HealthVault. This new functionality will streamline the information flow by enabling health records and data stored in the patient’s HealthVault account to be transferred into TrialMaster for inclusion with other information gathered during clinical trial participation.

Read More

OmniComm Systems’ TrialMasterTM EDC Solution Selected for Its Reputation for Meeting Aggressive Timelines.

Ability to meet challenges of early phase requirements drives Sponsor’s decision

Fort Lauderdale, FL, December 15, 2009 - OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that a West Coast biopharmaceutical company, who specializes in small molecule medicines across a number of therapeutic areas, has selected OmniComm’s TrialMaster EDC solution for conducting a Phase I study. The 9-month, 2-site study is planning to enroll over 80 subjects.

Read More

Beardsworth® Selects OmniComm Systems’ TrialMasterTM Solution for the Electronic Data Capture (EDC) of a Phase II Vaccine Study

Fort Lauderdale, FL, November 24, 2009 - OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Beardsworth, a full service contract research organization (CRO) who specializes in difficult therapeutic areas, has selected OmniComm’s TrialMaster EDC solution for conducting a Phase II vaccine study. The 3-year, 10-site study is planning to enroll 340 subjects. "After a careful selection process, we chose OmniComm Systems to be our preferred EDC provider," said Michael J. O’Brien, Beardsworth President and CEO. "OmniComm’s solid reputation, early adoption of industry standards, and the many features and benefits the platform offers, made it a logical choice."

Read More

OmniComm Systems Continues its Rapid Expansion by Opening a New Office in Monmouth Junction, NJ

Fort Lauderdale, FL, November 19, 2009 - OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC and eClinical marketplace, announced today that it has opened a new office in Monmouth Junction, NJ. The new location, situated equal distance between Princeton and Rutgers Universities, was chosen in part for its proximity to the Route One technology and pharmaceutical research corridor.

Read More

OmniComm’s TrialMasterTM EDC Solution Selected by Leading Medical Device Manufacturer for Phase IV Cardiovascular Device Study

Long Term Customers Continue to Propel OmniComm’s Fast-Paced Growth

Fort Lauderdale, FL, November 17, 2009 - OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, announced today that a leader in the medical device industry has selected OmniComm’s TrialMaster EDC solution for the data capture of a Phase IV cardiovascular study. The 24-months, 7-site study will enroll 100 subjects.

Read More

OmniComm Ranks Number 284 on Deloitte’s 2009 Technology Fast 500TM for Fastest Growing Companies in North America.

Attributes its 455% Percent Revenue Growth to the superiority of its Electronic Data Capture (EDC) solution TrialMasterTM and its "First in Customer Service” philosophy.

Fort Lauderdale, FL, October 20, 2009 - OmniComm Systems, Inc. (OTC: OMCM.OB)today announced that it ranked number 284 on Technology Fast 500™, Deloitte LLP’s ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the five-year period from 2004–2008. OmniComm grew 455% percent during this period.

Read More

OMNICOMM DELIVERS ITS STUDY DATA TABULATION MODEL (SDTM) EXPORT TOOL AHEAD OF ITS PLANNED 2010 RELEASE DATE.

Fort Lauderdale, FL, October 16, 2009 - /Marketwire/ OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the electronic data capture (EDC) marketplace, announced today that its new SDTM solution is ready, ahead of schedule, and is available to its customers for deployment and implementation into clinical studies. This new solution was developed for OmniComm’s flagship EDC product, TrialMaster™ and will allow for mapping and exporting of data directly into the CDISC SDTM format, ensuring an accelerated pathway towards electronic submission of clinical data. OmniComm is a CDISC ODM certified and is known in the industry for its commitment to standards and for bringing innovative eClinical solution to the life science industry. OmniComm’s TrialMaster solution has supported the CDISC ODM, CDASH (including naming conventions and domain structures), HL7, E2B, and caBIG standards for years, and with the addition of CDISC SDTM, will be the first EDC company to leverage all of the industry leading standards in a single solution.

Read More

OMNICOMM SYSTEMS' TRIALMASTERTM ADDED TO KENDLE'S SUITE OF ECLINICAL SOLUTIONS IN MULTI-YEAR ENTERPRISE AGREEMENT.

Fort Lauderdale, FL, September 30, 2009– /Marketwire/ -- OmniComm Systems, Inc. or the "Company" (OTC Bulletin Board: OMCM ), one of the fastest-growing companies in the EDC marketplace, today announced that Kendle, a leading global clinical research organization (CRO), will add OmniComm’s TrialMaster EDC solution to its current eClinical offerings in a multi-year enterprise-wide agreement.

Read More

OMNICOMM SYSTEMS INC. EXPANDS ITS SUCCESSFUL CRO PREFERRED PROGRAMTM BY SIGNING ON THREE NEW CRO PARTNERS.

Fort Lauderdale, FL, September 1, 2009 -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB ), a leader in integrated electronic data capture (EDC) solutions for clinical trials, and one of the fastest growing companies in the EDC marketplace, announced today that three additional clinical research organizations (CRO) have joined its rapidly expanding partnership program, the CRO Preferred Program. The partnership allows CROs in the program to offer their clients the flexible, intuitive and robust EDC solution, TrialMasterTM, for clinical trials. The CRO Preferred Program’s distinct advantages include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm, a dedicated hosted environment and comprehensive training and support for TrialMaster.

Read More

Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider

Fort Lauderdale, FL, August 25, 2009 -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB ), a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that their EDC tool, TrialMasterTM, has been selected by Pleiad, Inc., a Cambridge, Massachusetts based Contract Research Organization (CRO) with European operations in the U.K., to provide eClinical services to its customers. Pleiad’s investment will provide it with the products and services to manage two upcoming studies investigating the use of ophthalmic medical devices. This partnership is expected to generate more than $1 million to OmniComm over the next few years. Pleiad has worked with the TrialMaster EDC tool since April 2008 under OmniComm’s CRO Preferred Program, and is now transitioning to a Technology Transfer model in order to provide greater value to its customers engaged in these important clinical trials.

Read More

Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinson’s Disease

Fort Lauderdale, FL, August 20, 2009 -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB ), one of the fastest growing companies in the EDC marketplace, today announced that Impax Pharmaceuticals, the brand division of Impax Laboratories, Inc., Hayward, CA, has selected the TrialMaster EDC solution for conducting a Phase III study in patients with Parkinson’s Disease. "While managing a global multi site clinical trial there can be significant challenges in getting trial data when you want it and in the format that you need it," said Suneel Gupta, PhD, Chief Scientific Officer for Impax. "The TrialMaster EDC solution provides us with an intuitive and easy to use export tool that simplifies the process. After considering multiple different EDC solutions, we selected OmniComm Systems based on its customer driven approach and reputation for delivering unparalleled service and support. Additionally, its support of industry standards has enabled us to meet our very tight corporate timelines for this important study."

Read More

Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComm’s CRO Preferred Program

Fort Lauderdale, FL, August 18, 2009 -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB ), a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing. The study will be conducted at over 30 sites and will recruit up to 300 patients over the course of two years. Amarex also joins OmniComm’s CRO Preferred Program, which will allow them to offer OmniComm’s flexible, robust electronic data capture solution, TrialMasterTM, to their clients. Amarex also benefits from the CRO Program’s distinct advantages that include fixed pricing with no hidden fees, complete sales and marketing support, and dedicated hosting services in OmniComm’s world class hosting facility.

Read More

Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study

FT. LAUDERDALE, Fla., August 13, 2009 -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that it has been selected by a leading European based Contract Research Organization (CRO) to provide eClinical solutions for a pivotal Phase III study in rheumatoid arthritis (RA). Phase III clinical studies serve to establish the safety and efficacy of investigational new drugs, in large patient populations, and are the last step prior to review for approval by the regulatory authorities, such as FDA and the EMEA . This particular RA study is expected to last 48 months and enroll close to 300 patients in 20 sites located in Europe.

Read More

Major Biotechnology Company Selects OmniComm Systems to Provide eClinical Solutions for Phase I HIV Trials

FT. LAUDERDALE, Fla., August 10, 2009 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ), a global leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that a major West coast biopharmaceutical company has selected OmniComm to provide eClinical solutions for two of its phase I HIV studies involving over 100 patients. Both HIV studies are expected to run for approximately 7 months. OmniComm Systems has already done extensive work with this client in different therapeutic areas.

Read More

OmniComm Systems Signs Licensing Deal with West Coast Clinical Research Organization<

FT. LAUDERDALE, Fla., August 6, 2009 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ), a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has entered into a licensing agreement with a west coast Clinical Research Organization (CRO) for the use of ther TrialMaster™ solution in a Technology Transfer model. The agreement is expected to generate more than $1.1 million from licensing, maintenance, hosting, and consulting fees for OmniComm over the next three years. It also allows this leading CRO to expand its offering to its customers to include the latest in cutting edge technologies for electronic data capture.

Read More

OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.

FT. LAUDERDALE, Fla., August 4, 2009 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ), a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that the company has acquired the EDC assets of UK based, clinical software provider, Logos Technologies, Ltd. The acquisition will be operated by OmniComm’s UK subsidiary, OmniComm Ltd. Logos’ exceptional software is used to collect clinical trial data gathered while conducting Phase I clinical trials. Phase I clinical trials are the first stage of the US or International regulatory approval process, in order to get new drugs and medical devices to the marketplace. The Logos software complements OmniComm’s TrialMaster® software, which is primarily used in later stage clinical trials. The Logos products cover all aspects of the Phase I process from subject recruitment and clinical workflow management to laboratory sample management. Regular EDC solutions for later stage trials do not include a pro-active data collection system, which is imperative for the very time-controlled data collection during many early stage clinical studies. There are only 3 commonly known Phase I EDC systems in the world that are capable of demonstrating this functionality.

Read More

Growing Midwestern Clinical Research Organization Selects OmniComm Systems to Provide eClinical Solutions for Phase IV Studies

FT. LAUDERDALE, Fla., July 30, 2009 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM ) , a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that a growing US Clinical Research Organization (CRO) has selected OmniComm to provide eClinical solutions in connection with two of the CRO’s Phase IV studies covering approximately 27 sites and more than 700 subjects. Additional details were not disclosed. Phase IV studies take place after a drug has been approved for marketing and are designed to provide broader experience in evaluating the safety and effectiveness of the new medicine in larger numbers of patients, subpopulations of patients, and to compare and/or combine it with other available treatments.

Read More

OmniComm Systems, Inc. Retains Emerging Growth Equities, Ltd., as its Strategic Financial Advisor

FT. LAUDERDALE, Fla., July 7 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials announced today that its Board of Directors has retained Emerging Growth Equities, Ltd. (EGE) as its strategic financial advisor to assist in evaluating strategic alternatives with a focus on acquisitions that may be available to the Company.

Read More

OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology

-- Acquisition Extends the Company’s Suite of Products and Increases Breadth of EDC Customers --

FORT LAUDERDALE, Fla. and PHILADELPHIA, June 23 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. ® (OTC Bulletin Board: OMCM) ("OmniComm") a leader in integrated electronic data capture (EDC) solutions for clinical trials, and eResearchTechnology, Inc. (Nasdaq: ERES) ("ERT"), a global provider of technology and services that enable the pharmaceutical, biotechnology, and medical device industries worldwide to collect, interpret, and distribute cardiac safety and clinical data, today announced that OmniComm has acquired the EDC business of ERT.

Read More

OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific

OMNICOMM CONTINUES ITS EXPANSION INTO EUROPE AND STRENGTHENS ITS SENIOR MANAGEMENT TEAM

FT. LAUDERDALE, Fla., May 12 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that it has strengthened its European presence and management team with the addition of Dr. Wolfgang Summa. As Executive Vice President, Europe & Asia/Pacific based in OmniComm’s Bonn, Germany facility, Dr. Summa will be focused on the expansion of our products and services throughout Europe and the Asia Pacific area.

Read More

clinicalprojects international GmbH Joins the OmniComm CRO Preferred Program(TM) and Chooses TrialMaster(TM) for Electronic Data Capture (EDC)

Contract Research Organization (CRO) Selects TrialMaster(R) for EDC

FT. LAUDERDALE, Fla., April 23 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that clinicalprojects international GmbH (CPI), a full service, global contract research organization based in Rheinbach, Germany, has become a member of OmniComm’s CRO Preferred Program. The partnership allows CPI to offer their clients the flexible, intuitive and robust EDC solution, TrialMaster, for clinical trials. The CRO program’s distinct advantages include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm, a dedicated, hosted environment, and comprehensive training and support for TrialMaster.

Read More

OmniComm Systems Announces 1st Quarter Results of Operations

FT. LAUDERDALE, Fla, April 22/PR Newswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated eClinical solutions for the clinical trials market today announced its results of operations for the first quarter of fiscal 2009

Read More

OMNICOMM SYSTEMS, INC. EXPERIENCES RECORD YEAR END RESULTS - $18 MILLION IN SIGNED CONTRACTS FOR THE YEAR 2008

FT. LAUDERDALE, FL – January 16, 2009 – /PR Newswire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced record breaking results for 2008 in new and repeat business that exceeded original expectations. A record jump of 80% in contracts over 2007 clearly validates OmniComm’s position as a major contender in the EDC Marketplace.

Read More

Sarah Cannon Research Institute Selects OmniComm Systems’, Electronic Data Capture Solution, TrialMasterTM, For Clinical Trials Management

FT. LAUDERDALE, FL – November 4, 2008 – /PR Newswire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated EDC solutions for clinical trials, today announced that after an extensive evaluation of the leading EDC vendors, the Sarah Cannon Research Institute (SCRI), www.sarahcannonresearch.com, has chosen to use OmniComm’s TrialMaster for their electronic data capture software and services needs. SCRI selected OmniComm for several key reasons, including TrialMaster’s functionality. However, the deciding factor was OmniComm’s responsiveness and the level of service that the company delivers, something that SCRI requires for their sites.

Read More

OmniComm Systems, Inc. Is Fueled By Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services

FT. LAUDERDALE, FL – October 29, 2008 – /PR Newswire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced another momentous quarter for new business. Signed contracts through the first 3 quarters of 2008, totaling $15.8M, are exceeding projected expectations for the year.

Read More

OMNICOMM SYSTEMS, INC. TO PRESENT AT THE NOBLE FINANCIAL EQUITY CONFERENCE

FT. LAUDERDALE, FL – August 12, 2008 – OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Stephen Johnson, COO, and Ronald Linares, CFO, will present at the Fourth Annual Noble Financial Equity Conference at 7:30 a.m. (Pacific) on Tuesday, August 19, 2008 at the Loews Lake Las Vegas Resort, Nevada.

Read More

OMNICOMM SYSTEMS, INC. INDUSTRY EXPERTS TO DRIVE ELECTRONIC DATA CAPTURE (EDC) SESSIONS AT UPCOMING CLINICAL RESEARCH MEETINGS

Clinical Research Veterans to conduct sessions on EDC implementation

FT. LAUDERDALE, FL – August 8, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that several of their key executives have been asked to conduct sessions on the benefits of electronic data capture and the use of effective implementation methods to maximize the potential benefits of using EDC. The sessions will be held at two of the industry’s premier meetings, The Data Monitoring Committees Conference in August in Philadelphia and the Society for Clinical Data Management Fall Conference in September in Dallas.

Read More

COLORADO PREVENTION CENTER ADOPTS ELECTRONIC DATA CAPTURE AND CHOOSES OMNICOMM SYSTEMS, INC. AS ITS PREMIER VENDOR

Academic Research Organization becomes an OmniComm CRO Preferred Program™ partner

FT. LAUDERDALE, FL – August 5, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Colorado Prevention Center (CPC) has chosen OmniComm as their preferred provider as they move from paper data collection to EDC for their clinical trials. CPC delivers all of the traditional services of a CRO with additional emphasis on the quality of the science and trial conduction. Joining the CRO Preferred Program allows them to offer superior electronic data capture services and support to their clinical development clients worldwide.

Read More

OMNICOMM SYSTEMS, INC. INTRODUCES THE TRIALMASTER™ eLEARNING TOOL

Company augments their full service training suite, OmniLearn™, with a state-of-the-art eLearning tool

FT. LAUDERDALE, FL – August 4, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that the company introduced TrialMaster eLearning, their robust, self-paced education tool. The on-demand training module joins a comprehensive suite of training options that are a part of OmniLearn for TrialMaster. OmniLearn users can take advantage of Instructor led live training, Instructor led web-based training, Train-the-Trainer sessions, customized training packages and now eLearning. One of the company’s largest clients, a major west coast biotechnology company, is using the TrialMaster eLearning tool for 10 international studies at 427 sites worldwide.

Read More

OMNICOMM SYSTEMS, INC. HAS ANOTHER RECORD BREAKING QUARTER DELIVERING ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS & SERVICES

$8.7 million in contracts are signed in Q2 2008, representing a 300% increase from Q2 last year

FT. LAUDERDALE, FL – July 7, 2008 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced another landmark quarter for new business. This is the 3rd quarter in a row that OmniComm has surpassed its previous best quarter. Signed contracts through the first 2 quarters of 2008, totaling almost $12M, have already surpassed signed contracts from all of last year.

Read More

CITY OF HOPE, AN NCI-DESIGNATED COMPREHENSIVE CANCER CENTER, GOES LIVE USING OMNICOMM'S FIRST IN FUNCTIONALITY™, ELECTRONIC DATA CAPTURE (EDC) SOLUTION

TrialMaster™ v4 is used in a Phase I Single Agent Study of Pazopanib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction

FT. LAUDERDALE, FL May 22, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture solutions for clinical trials, today announced that City of Hope, a National Cancer Institute (NCI)-designated comprehensive cancer center, has gone live using TrialMaster for EDC in the first of many trials that will benefit from using a unique library of National Cancer Institute (NCI) related reusable electronic case report forms (eCRFs) developed by OmniComm and City of Hope. The trial, coordinated by City of Hope on behalf of the California Cancer Consortium, will enroll between 72 and 132 patients and will involve at least 17 participating centers, including international sites.

Read More

OMNICOMM SYSTEMS, INC. ENTERS INTO AN ENTERPRISE ELECTRONIC DATA CAPTURE (EDC) AGREEMENT WORTH $8-10 MILLION WITH A MAJOR BIOTECHNOLOGY COMPANY

Company continues to expand its footprint by providing leading-edge, integrated EDC solutions and services to its rapidly growing customer base

FT. LAUDERDALE, FL May 19, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that the company has entered into a 5-year, multi-million dollar enterprise agreement with a major west coast biotechnology company. The agreement allows the biotech company to take full advantage of OmniComm's First in Functionality™, EDC solution, TrialMaster™ for up to 10 concurrent trials per year. The biotech company will strategically utilize OmniComm's EDC application to assist in managing their global clinical trials and clinical related data. The enterprise deal includes complete licensing, services and technical support for these 10 concurrent studies. The agreement also provides for an option to exceed 10 concurrent studies per year for a predetermined ‘per study' price.

Read More

OMNICOMM SYSTEMS, INC.'S SUCCESS IN DELIVERING TOP QUALITY ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS & SERVICES CONTINUES WITH YET ANOTHER STRONG QUARTER

Over $3 million in contracts are booked in Q1, representing an increase in bookings of 40% from Q1 last year.

FT. LAUDERDALE, FL April 21, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that customer momentum is building as the company continues to experience dynamic growth. OmniComm attributes its success to providing quality EDC solutions and services and partnering with innovative companies that deliver the clinical trial support services that today's drug development companies demand.

Read More

OMNICOMM SYSTEMS, INC. TO PRESENT AT AeA MICRO CAP FINANCIAL CONFERENCE

FT. LAUDERDALE, FL April 30, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that its Chief Operating Officer, Stephen Johnson, and its Chief Financial Officer, Ron Linares, will present at the AeA Micro Cap Financial Conference in Monterey, CA

Read More

CRITERIUM INC. CHOOSES OMNICOMM SYSTEMS, INC. FOR ELECTRONIC DATA CAPTURE (EDC) SOFTWARE AND SERVICES AND JOINS THE CRO PREFERRED PROGRAM™

Veteran Contract Research Organization (CRO) recommends TrialMaster™ for EDC

FT. LAUDERDALE, FL April 8, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Criterium Inc., the full service, global, technology driven contract research organization has become a member of OmniComm's CRO Preferred Program. The partnership allows Criterium to offer their clients the flexible, intuitive and robust EDC solution, TrialMaster for clinical trials. Criterium will also benefit from the CRO program's distinct advantages that include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm in the selection process, a dedicated, hosted environment and comprehensive training and support for TrialMaster.

Read More

OMNICOMM SYSTEMS, INC. AND LOGOS TECHNOLOGIES PARTNER TO PROVIDE SUPERIOR ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS FOR PHASE I IV CLINICAL TRIALS

Leader in integrated EDC solutions and time tested experts in early Phase EDC join forces and integrate their systems to expand the use of EDC in Phase I-IV studies

FT. LAUDERDALE, FL April 4, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that OmniComm will partner with Logos Technologies and create an integrated solution with ALPHADAS ®, the premier electronic data capture solution designed specifically for Phase I clinical trials. The combined technologies will be available for use by customers using the TrialMaster™, First in Functionality™, EDC solution. The collaboration will allow customers that are conducting clinical research in Phase I to take advantage of a clinical study management and fully mobile electronic data capture system to capture data directly from the patient's bedside. For those clients running Phase I-IV clinical studies, the combination will unify the capture, reporting, exporting and archival of clinical data into a common, cost-effective, web-based, user-interface. The final warehouse for data may reside in SQL, Oracle Clinical® database tables or in SAS®.

Read More

OMNICOMM SYSTEMS, INC. APPOINTS STEPHEN JOHNSON AS CHIEF OPERATING OFFICER

Leader in integrated EDC solutions promotes key industry veteran to spearhead operations

FT. LAUDERDALE, FL April 3, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Stephen Johnson has been promoted to Chief Operating Officer for OmniComm. Mr. Johnson joined the company in September 2006 as Senior Vice President of Business Development and has been promoted to roles of increasing responsibility over the last 18 months as the company has experienced record growth. Mr. Johnson most recently held the position of Executive Vice President of Business Development and Professional Services. In his new role as COO, he will be responsible for sales, marketing, professional services and clinical services and support.

Read More

Pleiad Devices Joins OmniComm's CRO Preferred Program™ And Chooses The TrialMaster™ Electronic Data Capture (EDC) Solution Exclusively For Clinical Trials

CRO and EDC companies launch partnership and deliver integrated solutions for medical device companies conducting clinical research

FT. LAUDERDALE, FL March 12, 2008 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that after extensive evaluation of the industry's leading EDC systems, Pleiad Devices has chosen OmniComm as its preferred EDC vendor. Pleiad is an international Medical Device Contract Research Organization (CRO) with offices located in Europe and the US. The company's primary focus is providing clinical trial support services for medical device companies. As part of the partnership with OmniComm, Pleiad will take full advantage of the flexible, intuitive and robust EDC solution, TrialMaster, in an upcoming ophthalmology trial.

Read More

OmniComm Systems, Inc. Experiences Banner Year End Results Delivering Electronic Data Capture (EDC) Services And Support For Clinical Trials

2007 Positions OmniComm as a Major Contender in the Electronic Data Capture Marketplace

FT. LAUDERDALE, FL - January 9, 2008 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that record growth for the company combined with international expansion and a dedicated focus on the company's support services infrastructure have positioned OmniComm as a significant player among the market leaders and a technological leader for integration with EDC related products and services.

Read More

OmniComm Systems, Inc. Is Chosen By Valeant Pharmaceuticals International For Electronic Data Capture

Major pharmaceutical company chooses the TrialMasterTM EDC solution due to a clear distinction in superior services and support

FT. LAUDERDALE, FL - January 7, 2008 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that following a rigorous evaluation of six electronic data capture vendors, OmniComm's TrialMaster software was selected by Valeant Pharmaceuticals as its first choice for EDC. The initial vendor evaluation began with six EDC companies that quickly narrowed down to two major players. TrialMaster's user-friendly, intuitive and feature rich functionality were important elements in the final decision, but OmniComm's customer referrals for superior service and customer support became the deciding factor.

Read More

QST Consultations, Ltd. Chooses OmniComm Systems, Inc. For Electronic Data Capture (EDC) In A Top 15 Pharmaceutical, Phase IV Clinical Trial

OmniComm's CRO Preferred Program™ partner chooses the TrialMaster EDC solution for a Phase IV, multi-site international allergy study

FT. LAUDERDALE, FL - December 13, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that QST Consultations, Ltd. has selected OmniComm's integrated EDC solution, TrialMasterTM, for a Phase IV, multi-site international allergy study. QST is a Contract Research Organization (CRO) that provides clinical trial support for the pharmaceutical and medical device industries. QST has successfully used TrialMaster for EDC clinical trial support in the past and has recently joined OmniComm's CRO Preferred Program.

Read More

OmniComm Systems, Inc. And City Of Hope Collaboration To Benefit Entire Cancer Research Community

EDC Company to collaborate with leading Cancer Center to build standards-based eCRFs and make available outcome of collaboration to other users.

FT. LAUDERDALE, FL - December 4, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that City of Hope (a recent license customer of the TrialMasterTM product suite) and OmniComm are working together to develop a set of caDSR derived standardized case report forms and reporting tools to support National Cancer Institute (NCI) reporting requirements.

Read More

Cardium Therapeutics And Its Subsidary, Tissue Repair Company (TRC), Extend Their Relationship With OmniComm Systems Inc. As Their Preferred Web-Based Data Collection And Management Solution

Phase 2b clinical trial of Excellarate™ for Diabetic Ulcers to use OmniComm's First in Functionality™ electronic data capture (EDC) solution, TrialMasterTM

FT. LAUDERDALE, FL - November 28, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that they will provide EDC services to Tissue Repair Company for a randomized, double-blind, placebo-controlled, comparator arm clinical trial to evaluate the safety and efficacy of Excellarate for the potential treatment of non-healing diabetic foot ulcers.

Read More

OmniComm Systems, Inc. Continues To Have Success In Delivering Superior Integrated Electronic Data Capture (EDC) Solutions For Clinical Trial Research In Third Quarter 2007

Company Signs An Additional 10 New Business Deals With A Combination Of New And Existing Customers To Use TrialMasterTM For Electronic Data Capture

FT. LAUDERDALE, FL - October 15, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that they have closed 10 new business deals in Q3, totaling 35 deals for the year. Key market segments for the new business include pharmaceutical companies, including 2 Top 50 pharma company deals in the mix, biotechnology companies and contract research organizations (CROs). The increase in CRO business has been the primary catalyst for growth in Q3.

Read More

OmniComm Systems, Inc. Drives Industry Discussion On Designing Adaptive Clinical Trials

Company To Host Xtalks Webinar Featuring Dr. Mark Chang Of Millenium Pharmaceuticals

FT. LAUDERDALE, FL - September 5, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced Dr. Mark Chang, co-author of the book "Adaptive Design Methods in Clinical Trials" and the upcoming book "Adaptive Design Theory and Implementation Using SAS and R" will be the feature guest speaker in this thought provoking discussion on designing Adaptive Clinical Trials.

Read More

OmniComm Systems, Inc. Appoints 18-Year Industry Veteran Dr. Yvonne Rollinger To Spearhead Global Clinical Electronic Data Capture Services

Latest Hire Brings The Total To 15 Additional Industry Experienced Executives Hired In Q2, 2007 To Support The Needs Of The Company's Rapidly Growing Customer Base

FT. LAUDERDALE, FL - August 16, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that it has strengthened its client services and support management team with the addition of Dr. Yvonne Rollinger. As Director of Clinical Operations based in OmniComm's Bonn, Germany facility, Dr. Rollinger will be responsible for leading the charge to deliver best-in-class clinical services and client support to OmniComm's rapidly growing base of EDC customers.

Read More

OmniComm Systems, Inc. Responds To Industry's Growing Demand For Integrated Electronic Data Capture (EDC) Solutions And Signs 15 New Deals In Second Quarter 2007

A Mix Of New And Existing Companies Choose TrialMasterTM Over Other EDC Vendors For Their Clinical Trials

FT. LAUDERDALE, FL - July 23, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that they have closed 15 new business deals in Q2, 2007. Key market segments for the new business include pharmaceutical, medical device, contract research organizations (CRO) and academic medical center customers, including a high profile Top 50 pharmaceutical company. TrialMaster will be implemented in both an ASP, fully hosted environment for the new trials and also in 2 new Technology Transfer deployments for those clients that want to bring EDC in-house.

Read More

City Of Hope Selects TrialMaster To Support Clinical Trials

OmniComm Systems, Inc. to deploy a Technology Transfer of the TrialMasterTM electronic data capture (EDC) solution for clinical data collection

FT. LAUDERDALE, FL - July 11, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that City of Hope has selected OmniComm's EDC solution, TrialMaster and has entered into negotiations on the contract to support its clinical trials, including Principal Investigator initiated and federally funded trials. City of Hope also plans to utilize the OmniComm solution to provide EDC capabilities for the California Cancer Consortium which is comprised of City of Hope, UC Davis Cancer Center, University of Southern California/Norris Comprehensive Cancer Center, University of Pittsburgh Cancer Institute and affiliated sites.

Read More

Pharmatech, Inc. Selects OmniComm Systems, Inc. As Its Preferred Electronic Data Capture (EDC) Vendor And Enters Into A Strategic Partnership To Co-Develop Next Generation Solutions For Improving Patient Accrual

CRO and EDC companies team up to co-develop a Patient Repository Solution for improving patient accrual for their physicians conducting clinical trial research.

FT. LAUDERDALE, FL - July 2, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it will partner with Pharmatech, Inc., a Research Management Organization (RMO), to build a patient registry database that will improve patient accrual in clinical trials. The database will leverage the data mining functionality inherent in OmniComm's First in Functionality™ TrialMasterTMEDC solution to facilitate the screening and identification of patient candidates for cutting-edge oncology research. OmniComm will be the exclusive choice for Pharmatech and their network physicians who utilize EDC for clinical trials. Pharmatech will begin using TrialMaster in a multi-center, Phase II clinical trial for advanced Non-Small Cell Lung Cancer (NSCLC).

Read More

OmniComm Systems, Inc. Appoints Fernando Montero To Its Board Of Directors

FT. LAUDERDALE, FL - June 18, 2007 - /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced the appointment of Fernando Montero to its Board of Directors.

Mr. Montero, who will chair the Board's Audit Committee, has spent many years in various senior financial, operations and executive management positions.

Read More

OmniComm Systems, Inc. Completes Integration Of Their Electronic Data Capture Solution (EDC), TrialMasterTM, With The Industry Leading Clinical Data Management System (CDMS), Oracle Clinical

Integration allows customers of OmniComm Systems’ TrialMaster and Oracle Clinical to implement a solution that supports electronic and paper-based data collection in a unified solution for clinical research

FT. LAUDERDALE, FL – June 15, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced that it has completed Phase II of their integration project with the industry’s leading Clinical Data Management System for paper-based data collection. OmniComm released Phase I of their integration several months ago, which allows customers using TrialMaster to generate a data export in Oracle Clinical standard format that can be imported into Oracle Clinical. The integration makes it possible for companies using Oracle Clinical to store all of their EDC trial data in the same database as their paper-based data.

Read More

Pharmaceutical And Life Sciences Executive Ken Light Joins OmniComm Systems, Inc. As Senior Vice President Of Professional Services

Senior healthcare executive poised to spearhead electronic data capture (EDC) technology transfer services for government institutions and leading pharmaceutical, biotechnology, medical device and CRO companies

FT. LAUDERDALE, FL – June 13, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that, effective July 9, 2007, Ken Light will be joining OmniComm’s management team and will be responsible for leading the delivery of technology transfer and implementation services for customers seeking on-site adoption of EDC technology.

Read More

OmniComm Systems, Inc. Wins A Phase II, Multi-Center International Clinical Trial For A Major West Coast Biopharmaceutical Company

Electronic Data Capture (EDC) company poised to deliver hosted EDC services for the first in a series of clinical trials for this industry leader

FT. LAUDERDALE, FL – June 11, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced that it has begun working with a multi-billion dollar West Coast global pharmaceutical company on a Phase II, multi-center study. OmniComm’s subsidiary in Europe, OmniComm Europe GMBH located in Bonn, Germany will provide full ASP hosted support and services for the duration of the trial.

Read More

OmniComm Systems, Inc. Expands Internationally And Launches Office In Bonn, Germany

Electronic data capture (EDC) company opens additional European location to support international and US clients conducting global clinical trials

FT. LAUDERDALE, FL – June 7, 2007 – /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC market place, today announced that it has opened OmniComm Europe GMBH in Bonn, Germany. OmniComm is expanding its global presence to support the increase in clinical trials being conducted by their clients internationally. The Bonn office will provide enhanced local project management and study build activities, along with sales & marketing and local language Help Desk support.

Read More

OmniComm Systems, Inc. Successfully Integrates Their TrialMaster Electronic Data Capture (EDC) Solution With The National Cancer Institute's Cancer Data Standards Repository

EDC solution's integration creates pre-populated global library of NCI developed metadata for customers conducting NCI sponsored clinical trials

FT. LAUDERDALE, FL May 15, 2007 /MarketWire/ - OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that it has completed the first commercial integration of an EDC solution with the NCI's Center for Bioinformatics (NCICB) cancer Data Standards Repository (caDSR). This integration allows customers conducting cancer research to take full advantage of pre-populated global libraries of NCI-developed metadata for their clinical trials.

Read More


 


2101 West Commercial Blvd. Suite 4000 Ft. Lauderdale, FL 33309
877-GO-TO-EDC | 877-468-6332
Home | About Us | eClinical Solutions | Newsroom | Contact